Metsera, Inc. - Common Stock (NQ:MTSR)

'It's Getting Ugly,' Analyst Says As Pfizer Escalates Its Gloves-Off Fight For Metsera ↗

November 06, 2025

Metsera stock surged Thursday on reports Pfizer has matched Novo Nordisk's $10 billion bid to buy the obesity-focused biotech.

Novo Nordisk Snaps 11-Day Losing Streak After Court Rejects Pfizer’s Challenge To $10B Metsera Deal ↗

November 05, 2025

Delaware Chancery Judge Morgan Zurn ruled that Pfizer’s objections did not justify delaying Novo’s $10 billion acquisition of obesity-drug startup Metsera.

Three factors took Viking's shares higher in the month.

Topics Law Enforcement

Here's Why Shares in Viking Therapeutics Shot Higher in October ↗

November 05, 2025

Palantir, Hertz, Metsera, Uber, DraftKings: Stocks Making The Biggest Moves Today ↗

November 04, 2025

Novo Nordisk Q3 Preview: Analysts See Profit Drop As Obesity Market Cools, Pfizer Tensions Rise ↗

November 04, 2025

The Battle For Metsera Acquisition Heats Up As Pfizer Files A Second Lawsuit ↗

November 03, 2025

Retail Investors Now Expect Viking Therapeutics To Bag A Deal After Novo Nordisk, Pfizer Engage In A Bidding War For Rival Metsera ↗

October 30, 2025

Can Novo Nordisk’s ‘Attractive’ Fundamentals Outweigh Slowing Wegovy Sales And A $149 Price Cap? ↗

November 05, 2025

Novo Nordisk cut its 2025 profit and sales forecasts as slower GLP-1 growth and pricing pressure hit margins.

Novo, Pfizer Are Battling To Buy The Future Of Weight-Loss — But Viking Already Owns It ↗

Topics Lawsuit

November 04, 2025

Viking Global's $45 million investment in Metsera, a biotech company is caught in a bidding war between Pfizer and Novo Nordisk.

Via Benzinga

Pfizer, Novo Nordisk Intensify Fight For Metsera As Buyout Offers Continue To Climb ↗

November 04, 2025

Novo Nordisk boosts its Metsera bid to $62.20 per share, valuing the company at $10 billion and outbidding Pfizer in the escalating takeover fight.

Via Benzinga

Novo Sweetens Its Bid For Metsera, Pledging Up To $10 Billion ↗

November 04, 2025

Novo Nordisk said it would pay up to $10 billion to acquire obesity-focused Metsera, topping Pfizer's recently hiked bid.

Novo Nordisk Submits Revised Bid For Metsera, Enters A Bidding War With Pfizer ↗

October 30, 2025

Metsera said that it would be entitled to terminate its merger agreement with Pfizer if Novo’s proposal continues to be superior.

Metsera Gets Revised Bids From Pfizer, Novo Nordisk: Here’s Why It Matters ↗

November 04, 2025

Pfizer Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗

November 04, 2025

Via Benzinga

Did Novo Nordisk Just Say "Checkmate" to Pfizer? ↗

November 03, 2025

These two leading drugmakers are fighting over a promising GLP-1 candidate.

Metsera called Pfizer's claims "nonsense" in a follow-up Monday to Pfizer's lawsuit against Metsera and Novo Nordisk.

Topics Intellectual Property

Metsera Calls Pfizer's Claims 'Nonsense' In Latest Buyout Battle Salvo ↗

November 03, 2025

Pfizer sues Metsera and Novo Nordisk, alleging breach of contract and antitrust violations over a rival $9 billion bid challenging its $4.9 billion merger deal.

Topics Economy Lawsuit

Pfizer Accuses Novo Nordisk Of Antitrust Violations In Metsera Takeover Battle ↗

November 03, 2025

Via Benzinga

Topics Lawsuit

Meet the 7% Yield Dividend Stock That Could Soar in 2026 ↗

November 03, 2025

This out-of-favor drug maker is taking the steps needed to ensure it not only survives but thrives over the long term.

Pfizer stock has dropped 50% over the past three years.

Topics Intellectual Property World Trade

Is It Time to Dump Your Shares of Pfizer? ↗

November 02, 2025

Pfizer sued Metsera and Novo Nordisk on Friday to prevent Novo's proposed $6.5 billion takeover of the smaller company.

Topics Intellectual Property

Pfizer Sues Novo Nordisk And Metsera To Block The Proposed $6.5 Billion Deal ↗

October 31, 2025

Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise ↗

Topics Law Enforcement Lawsuit

October 31, 2025

Traders on Stocktwits linked Novo Nordisk’s renewed bid for Metsera to competition from Viking’s obesity drug VK2735, fueling further optimism.

Novo Nordisk kicked off a battle with Pfizer on Thursday, making an unsolicited $6.5 billion bid for obesity-focused Metsera.

10 Health Care Stocks Whale Activity In Today's Session ↗

October 30, 2025

Via Benzinga

Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera ↗

October 30, 2025

Novo Nordisk's $9 billion offer for Metsera challenges Pfizer's existing merger deal, prompting sharp criticism and potential legal action.

Topics Economy Government

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 30, 2025

Via Benzinga

Pfizer Blasts Novo Nordisk's $9 Billion Counteroffer For Metsera As 'Reckless' ↗

October 30, 2025

Via Benzinga

The market is filled with gapping stocks in Thursday's session. ↗

October 30, 2025

Today's session on Thursday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday ↗

October 30, 2025

Via Benzinga

Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

October 30, 2025

Via Benzinga

2 High-Yield Stocks With Fresh Catalysts ↗

October 29, 2025

Income investors can capture yields above 5% from companies executing business transformations.